New peptide comprising its amino acid sequence, used in pharmaceutical composition for preventing or treating an inflammatory disease, where inflammatory disease is selected from atherosclerosis, diabetes, asthma, liver-diseases, rheumatoid arthritis, lung infections, and stroke
	SHARMA S S; TRIPATHY R K; AHMED S; PANDE A H
	2023-10-06
专利权人	NAT INST PHARM EDUCATION & RES (NAPH-Non-standard)
申请日期	2023-10-06
专利号	IN202311067164-A
成果简介	NOVELTY - Peptide is new, where peptide comprises 41 amino acid sequence (SEQ ID NO: 1), and 45 amino acid sequence (SEQ ID NO: 2-6), given in the specification. The peptide is amidated at the C-terminal amino acid and acetylated at the N-terminal amino acid. USE - Peptide used in pharmaceutical composition for preventing or treating an inflammatory disease, where inflammatory disease is selected from atherosclerosis, diabetes, asthma, liver-diseases, rheumatoid arthritis, lung infections, stroke, intracranial hemorrhage, multiple sclerosis, Parkinson's disease, and Alzheimer's disease (claimed). No biological data given. ADVANTAGE - The peptide has an anti-inflammatory effect, where the peptide binds specifically to a pro-inflammatory lipid and inhibits one or more pro-inflammatory functions of the pro-inflammatory lipid. DETAILED DESCRIPTION - INDEPENDENT CLAIMS are included for: Pharmaceutical composition for preventing or treating an inflammatory disease, which comprises the peptide and a pharmaceutically acceptable carrier; and Method for treating or ameliorating an inflammatory disease in a subject, which involves administering to a subject a peptide having an amino acid sequence shown in SEQ ID NOs: 1-6.
IPC 分类号	A61P-025/00 ; A61P-025/28 ; A61P-029/00 ; A61P-009/00 ; C07K-014/47
国家	印度
专业领域	医药卫生
语种	英语
成果类型	专利
文献类型	科技成果
条目标识符	http://119.78.100.226:8889/handle/3KE4DYBR/20109
专题	中国科学院新疆生态与地理研究所
作者单位	NAT INST PHARM EDUCATION & RES (NAPH-Non-standard)
推荐引用方式 GB/T 7714	SHARMA S S,TRIPATHY R K,AHMED S,et al. New peptide comprising its amino acid sequence, used in pharmaceutical composition for preventing or treating an inflammatory disease, where inflammatory disease is selected from atherosclerosis, diabetes, asthma, liver-diseases, rheumatoid arthritis, lung infections, and stroke. IN202311067164-A[P]. 2023.

条目包含的文件
条目无相关文件。

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。